Event
ISTH Product Theater: Value of a rapid, on-demand ADAMTS13 Activity assay in the diagnosis and management of patients suspected of TTP
July 21, 2021, 07:00 AM - 07:45 AM (UTC)
Online
In this presentation, sponsored by Werfen, Prof. Agnes Veyradier, MD, PhD, head of the national reference laboratory for ADAMTS13 of the French Reference Center for Thrombotic Microangiopathies will discuss the clinical and health economic impact of an automated on-demand ADAMTS13 activity assay. Her presentation will include her experience with the HemosIL AcuStar ADAMTS13 Activity assay and its impact on suspected TTP patient management.
EVENTS
Upcoming Events
Acute Care
February 10, 2025
Impact of Hemolysis on Patient Management in Point-of-Care Whole Blood Samples
...
Hemostasis
January 14, 2025
State-of-the-Art Patient Treatments and the Impact of the Hemostasis Laboratory
...
More information